Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
Public ClinicalTrials.gov record NCT01549886. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Multi-Center, Phase 2 Study of Zevalin ([90Y]- Ibritumomab Tiuxetan) Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab- Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
Study identification
- NCT ID
- NCT01549886
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Spectrum Pharmaceuticals, Inc
- Industry
- Enrollment
- 5 participants
Conditions and interventions
Conditions
Interventions
- Moxtezafin Gadolinium Drug
- Rituximab Drug
- Y-90-Zevalin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2011
- Primary completion
- May 31, 2014
- Completion
- Apr 30, 2015
- Last update posted
- Oct 3, 2021
2011 – 2015
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alta Bates Summit Medical Center-Herrick | Berkeley | California | 94704 | — |
| Providence Saint Joseph Medical Center | Burbank | California | 91505 | — |
| Halifax Health- Center for Oncology | Daytona Beach | Florida | 32114 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Loyola University Chicago | Maywood | Illinois | 60153 | — |
| Oncology Specialists | Park Ridge | Illinois | 60068 | — |
| University of Massachusetts - Worcester | Worcester | Massachusetts | 01655 | — |
| Hackensack Medical Center | Hackensack | New Jersey | 07601 | — |
| West Virginia University, WVU Healthcare | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01549886, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2021 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01549886 live on ClinicalTrials.gov.